Natco Pharma (India) Price History
NATCOPHARM | 1,376 38.05 2.84% |
Below is the normalized historical share price chart for Natco Pharma Limited extending back to January 01, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Natco Pharma stands at 1,376, as last reported on the 1st of December, with the highest price reaching 1,384 and the lowest price hitting 1,340 during the day.
If you're considering investing in Natco Stock, it is important to understand the factors that can impact its price. Natco Pharma Limited has Sharpe Ratio of -0.0951, which conveys that the firm had a -0.0951% return per unit of risk over the last 3 months. Natco Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Natco Pharma's Standard Deviation of 1.7, mean deviation of 1.36, and Risk Adjusted Performance of (0.06) to check out the risk estimate we provide.
As of now, Natco Pharma's Total Stockholder Equity is increasing as compared to previous years. The Natco Pharma's current Liabilities And Stockholders Equity is estimated to increase to about 72.5 B, while Common Stock Shares Outstanding is projected to decrease to under 176.8 M. . Natco Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.2 K | 50 Day MA 1.4 K | Beta 0.519 |
Natco |
Sharpe Ratio = -0.0951
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NATCOPHARM |
Estimated Market Risk
1.67 actual daily | 14 86% of assets are more volatile |
Expected Return
-0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Natco Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Natco Pharma by adding Natco Pharma to a well-diversified portfolio.
Price Book 3.4457 | Enterprise Value Ebitda 8.749 | Price Sales 5.3983 | Shares Float 83.8 M | Dividend Share 1.25 |
Natco Pharma Stock Price History Chart
There are several ways to analyze Natco Stock price data. The simplest method is using a basic Natco candlestick price chart, which shows Natco Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 12, 2024 | 1591.09 |
Lowest Price | October 25, 2024 | 1290.47 |
Natco Pharma December 1, 2024 Stock Price Synopsis
Various analyses of Natco Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Natco Stock. It can be used to describe the percentage change in the price of Natco Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Natco Stock.Natco Pharma Price Rate Of Daily Change | 1.03 | |
Natco Pharma Price Daily Balance Of Power | 0.87 | |
Natco Pharma Price Action Indicator | 32.48 |
Natco Pharma December 1, 2024 Stock Price Analysis
Natco Stock Price History Data
The price series of Natco Pharma for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 300.62 with a coefficient of variation of 5.63. The daily prices for the period are spread out with arithmetic mean of 1428.94. The median price for the last 90 days is 1407.44. The company underwent 5:1 stock split on 26th of November 2015. Natco Pharma Limited issued dividends to stockholders on 2024-11-27.Open | High | Low | Close | Volume | ||
12/01/2024 | 1,348 | 1,384 | 1,340 | 1,376 | ||
11/29/2024 | 1,348 | 1,384 | 1,340 | 1,376 | 767,917 | |
11/28/2024 | 1,369 | 1,371 | 1,332 | 1,337 | 496,711 | |
11/27/2024 | 1,363 | 1,376 | 1,348 | 1,351 | 441,750 | |
11/26/2024 | 1,372 | 1,377 | 1,349 | 1,354 | 419,923 | |
11/25/2024 | 1,376 | 1,380 | 1,354 | 1,363 | 572,166 | |
11/22/2024 | 1,378 | 1,385 | 1,352 | 1,356 | 361,884 | |
11/21/2024 | 1,363 | 1,387 | 1,360 | 1,373 | 536,416 | |
11/20/2024 | 1,363 | 1,363 | 1,363 | 1,363 | 1.00 | |
11/19/2024 | 1,360 | 1,386 | 1,353 | 1,363 | 593,011 | |
11/18/2024 | 1,387 | 1,390 | 1,350 | 1,354 | 630,359 | |
11/14/2024 | 1,371 | 1,425 | 1,371 | 1,375 | 1,205,234 | |
11/13/2024 | 1,395 | 1,432 | 1,359 | 1,365 | 2,009,833 | |
11/12/2024 | 1,400 | 1,448 | 1,376 | 1,389 | 2,277,316 | |
11/11/2024 | 1,406 | 1,423 | 1,387 | 1,394 | 351,695 | |
11/08/2024 | 1,438 | 1,438 | 1,399 | 1,406 | 271,053 | |
11/07/2024 | 1,446 | 1,459 | 1,421 | 1,430 | 382,225 | |
11/06/2024 | 1,431 | 1,448 | 1,417 | 1,446 | 361,555 | |
11/05/2024 | 1,407 | 1,426 | 1,401 | 1,420 | 273,870 | |
11/04/2024 | 1,430 | 1,430 | 1,394 | 1,407 | 275,800 | |
11/01/2024 | 1,435 | 1,438 | 1,415 | 1,425 | 146,976 | |
10/31/2024 | 1,381 | 1,412 | 1,363 | 1,401 | 343,836 | |
10/30/2024 | 1,345 | 1,389 | 1,344 | 1,381 | 370,163 | |
10/29/2024 | 1,324 | 1,355 | 1,314 | 1,340 | 367,606 | |
10/28/2024 | 1,294 | 1,335 | 1,281 | 1,322 | 404,235 | |
10/25/2024 | 1,346 | 1,352 | 1,286 | 1,290 | 510,970 | |
10/24/2024 | 1,319 | 1,350 | 1,315 | 1,339 | 232,758 | |
10/23/2024 | 1,311 | 1,353 | 1,309 | 1,319 | 413,965 | |
10/22/2024 | 1,372 | 1,383 | 1,317 | 1,327 | 574,707 | |
10/21/2024 | 1,403 | 1,407 | 1,367 | 1,372 | 372,991 | |
10/18/2024 | 1,390 | 1,402 | 1,364 | 1,397 | 412,879 | |
10/17/2024 | 1,402 | 1,406 | 1,375 | 1,388 | 353,345 | |
10/16/2024 | 1,390 | 1,410 | 1,385 | 1,397 | 445,611 | |
10/15/2024 | 1,423 | 1,431 | 1,362 | 1,388 | 1,034,278 | |
10/14/2024 | 1,442 | 1,447 | 1,413 | 1,419 | 507,416 | |
10/11/2024 | 1,434 | 1,444 | 1,425 | 1,435 | 366,413 | |
10/10/2024 | 1,479 | 1,480 | 1,432 | 1,436 | 880,333 | |
10/09/2024 | 1,432 | 1,483 | 1,430 | 1,473 | 1,570,069 | |
10/08/2024 | 1,407 | 1,430 | 1,387 | 1,425 | 989,486 | |
10/07/2024 | 1,361 | 1,411 | 1,349 | 1,400 | 2,566,500 | |
10/04/2024 | 1,359 | 1,385 | 1,344 | 1,352 | 662,090 | |
10/03/2024 | 1,386 | 1,397 | 1,358 | 1,361 | 681,553 | |
10/01/2024 | 1,418 | 1,423 | 1,395 | 1,399 | 400,796 | |
09/30/2024 | 1,422 | 1,447 | 1,401 | 1,418 | 824,831 | |
09/27/2024 | 1,384 | 1,421 | 1,384 | 1,412 | 926,077 | |
09/26/2024 | 1,424 | 1,424 | 1,375 | 1,381 | 842,506 | |
09/25/2024 | 1,414 | 1,432 | 1,403 | 1,415 | 637,436 | |
09/24/2024 | 1,440 | 1,455 | 1,405 | 1,413 | 957,539 | |
09/23/2024 | 1,489 | 1,499 | 1,433 | 1,439 | 1,302,302 | |
09/20/2024 | 1,514 | 1,526 | 1,469 | 1,479 | 1,026,936 | |
09/19/2024 | 1,549 | 1,558 | 1,488 | 1,513 | 914,903 | |
09/18/2024 | 1,551 | 1,560 | 1,519 | 1,541 | 766,070 | |
09/17/2024 | 1,575 | 1,581 | 1,556 | 1,560 | 330,375 | |
09/16/2024 | 1,590 | 1,592 | 1,555 | 1,576 | 472,054 | |
09/13/2024 | 1,603 | 1,614 | 1,570 | 1,581 | 622,007 | |
09/12/2024 | 1,603 | 1,637 | 1,564 | 1,591 | 1,334,511 | |
09/11/2024 | 1,553 | 1,622 | 1,548 | 1,590 | 2,207,302 | |
09/10/2024 | 1,555 | 1,584 | 1,534 | 1,544 | 762,007 | |
09/09/2024 | 1,563 | 1,563 | 1,521 | 1,545 | 391,021 | |
09/06/2024 | 1,561 | 1,576 | 1,530 | 1,558 | 538,961 | |
09/05/2024 | 1,566 | 1,596 | 1,548 | 1,554 | 857,102 |
About Natco Pharma Stock history
Natco Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Natco is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Natco Pharma Limited will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Natco Pharma stock prices may prove useful in developing a viable investing in Natco Pharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 179.5 M | 176.8 M | |
Net Income Applicable To Common Shares | 8.2 B | 4.4 B |
Natco Pharma Quarterly Net Working Capital |
|
Natco Pharma Stock Technical Analysis
Natco Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
All Next | Launch Module |
Natco Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Natco Pharma's price direction in advance. Along with the technical and fundamental analysis of Natco Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Natco to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.21) | |||
Total Risk Alpha | (0.45) | |||
Treynor Ratio | (0.42) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Natco Stock analysis
When running Natco Pharma's price analysis, check to measure Natco Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natco Pharma is operating at the current time. Most of Natco Pharma's value examination focuses on studying past and present price action to predict the probability of Natco Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natco Pharma's price. Additionally, you may evaluate how the addition of Natco Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |